Greetings from MyCancerHaven!
We wanted to update you on our recent activities.
Here are the latest posts last week:
Blogs :
Pesticides as big a cancer risk as smoking
Podcast: Putting Patients First
US Cancer Survivor Population Projected to Reach 26 Million by 2040
Issues With Prior Authorization Result In Patients Forgoing Care
"Keep your face to the sunshine and you cannot see a shadow."
Zilurgisertib Alone or With Ruxolitinib Shows Good Tolerance in Myelofibrosis Patients
Also at MCH the News and Tweets never stop flowing!
Join Us at www.mycancerhaven.org
The Team @ MCH
Follow us on Facebook, Twitter (@My_Cancer_Haven), Instagram, YouTube, LinkedIn and TikTok
Note: Please do not reply to this e-mail as it is sent from an account that is not monitored. You can contact us by e-mail at contact@mycancerhaven.org.
We wanted to update you on our recent activities.
Here are the latest posts last week:
Blogs :
Pesticides as big a cancer risk as smoking
Podcast: Putting Patients First
US Cancer Survivor Population Projected to Reach 26 Million by 2040
Issues With Prior Authorization Result In Patients Forgoing Care
"Keep your face to the sunshine and you cannot see a shadow."
Zilurgisertib Alone or With Ruxolitinib Shows Good Tolerance in Myelofibrosis Patients
Also at MCH the News and Tweets never stop flowing!
Join Us at www.mycancerhaven.org
The Team @ MCH
Follow us on Facebook, Twitter (@My_Cancer_Haven), Instagram, YouTube, LinkedIn and TikTok
Note: Please do not reply to this e-mail as it is sent from an account that is not monitored. You can contact us by e-mail at contact@mycancerhaven.org.
